I can say for certain that the intent of management is to create a good product that will lead to a licensing deal or a partnership or a takeover.
It is very unlikely they would want to try and commercialise it and sell it themselves like the vascular patch.
Commentary on AGM questions., page-8
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.20 |
Change
0.050(0.33%) |
Mkt cap ! $292.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $20.85K | 1.367K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 132 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 290 | 2 |
View Market Depth
| Last trade - 10.50am 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |